C.G. Alexopoulos

967 citations

34 papers · 789 indexed · h-index 15

Impact in

Oncology top 10%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
Hepatology top 5%
- Hepatitis C virus research

Papers in

Oncology 20
- Lung Cancer Research Studies 6
- Cancer Treatment and Pharmacology 4
- Colorectal Cancer Treatments and Studies 4
- Inflammatory Biomarkers in Disease Prognosis 3
Pulmonary and Respiratory Medicine 14
- Lung Cancer Treatments and Mutations 8
- Gastric Cancer Management and Outcomes 4
- Lung Cancer Diagnosis and Treatment 4

Co-authors: Alec Avgerinos Michael Vaslamatzis E. Wiltshaw S. Raptis Theofanis Economopoulos Vincent Ninane Jean Klášterský J. Lecomte
Journals: European Journal of Cancer (5 papers)British Journal of Cancer (4 papers)Journal of Clinical Oncology (4 papers)Cancer Chemotherapy and Pharmacology (3 papers)Cancer (2 papers)
Partner nations: Greece Belgium United Kingdom

In The Last Decade

C.G. Alexopoulos

32 papers receiving 738 citations

Peers

Countries citing papers authored by C.G. Alexopoulos

Since Specialization

Citations

This map shows the geographic impact of C.G. Alexopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.G. Alexopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.G. Alexopoulos more than expected).

Fields of papers citing papers by C.G. Alexopoulos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.G. Alexopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.G. Alexopoulos. The network helps show where C.G. Alexopoulos may publish in the future.

Co-authors

The 25 scholars most cited alongside C.G. Alexopoulos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C.G. Alexopoulos Line = papers co-authored together C.G. Alexopoulos links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Measuring patient satisfaction in oncology units: interview-based psychometric validation of the âComprehensive Assessment of Satisfaction with Careâ in Greece European Journal of Cancer Care ·George Kritsotakis, A. Koutis, Aekaterini A. Kotsori, C.G. Alexopoulos, Αnastas Philalithis	2009	8
2	Chemotherapy improves low performance status lung cancer patients European Respiratory Journal ·Jean‐Paul Sculier, J.J. Lafitte, Marianne Paesmans, J. Lecomte, C.G. Alexopoulos, O Van Cutsem, V. Giner, Anna Efremidis, M.C. Berchier, T. Collon, A.P. Meert, Arnaud Scherpereel, Vincent Ninane, George Koumakis, Michael Vaslamatzis, Nathalie Leclercq, T. Berghmans	2007	20
3	Thrombocytosis in primary lung cancer Aekaterini A. Kotsori, Michail Vaslamatzis, C.G. Alexopoulos	2007	3
4	Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party British Journal of Cancer ·(unknown), T. Berghmans, J.J. Lafitte, J. Lecomte, C.G. Alexopoulos, O Van Cutsem, V. Giner, Anna Efremidis, M.C. Berchier, T. Collon, Anne‐Pascale Meert, Arnaud Scherpereel, Vincent Ninane, Nathalie Leclercq, M Paesmans, Jean‐Paul Sculier	2007	10
5	A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer Annals of Oncology ·Jean‐Paul Sculier, J.J. Lafitte, J. Lecomte, C.G. Alexopoulos, O Van Cutsem, V. Giner, Anna Efremidis, M.C. Berchier, T. Collon, Anne‐Pascale Meert, Arnaud Scherpereel, Vincent Ninane, M Paesmans, T. Berghmans	2007	18
6	A randomized comparison of darbepoetin alfa every three weeks with epoetin thrice weekly for chemotherapy induced anemia in nonhematological cancer patients Journal of Clinical Oncology ·Aekaterini A. Kotsori, Michael Vaslamatzis, C.G. Alexopoulos	2007	1
7	A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia Supportive Care in Cancer ·Yassine Lalami, Marianne Paesmans, M. Aoun, R. Munoz-Bermeo, K Reuss, Soraya Cherifi, C.G. Alexopoulos, Jean Klášterský	2004	24
8	A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer Annals of Oncology ·Jean‐Paul Sculier, J.J. Lafitte, J. Lecomte, Thierry Berghmans, J Thiriaux, M Florin, Anna Efremidis, C.G. Alexopoulos, P. Recloux, Vincent Ninane, P. Mommen, Marianne Paesmans, Jean Klášterský	2002	37
9	Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer British Journal of Cancer ·Sculier Jp, J.J. Lafitte, M Paesmans, J Thiriaux, C.G. Alexopoulos, J. Baumöhl, J Schmerber, George Koumakis, M Florin, C Zacharias, T. Berghmans, P. Mommen, Vincent Ninane, Jean Klášterský	2000	18
10	A phase II study of the effectiveness of docetaxel (Taxotere) in women with advanced breast cancer previously treated with polychemotherapy Cancer Chemotherapy and Pharmacology ·C.G. Alexopoulos, G. Rigatos, Anna Efremidis, A Papacharalambous, A. Alexopoulos, M. Vassilomanolakis, E. Patila	1999	12
11	A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer European Journal of Cancer ·J.P. Sculier, Marianne Paesmans, J Thiriaux, J. Lecomte, G. Bureau, V. Giner, George Koumakis, J.J. Lafitte, M.C. Berchier, C.G. Alexopoulos, C Zacharias, P. Mommen, Vincent Ninane, Jean Klášterský	1999	20
12	Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours British Journal of Cancer ·C.G. Alexopoulos, Michael Vaslamatzis, G Hatzidimitriou	1999	86
13	Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU) European Journal of Cancer ·Eric Van Cutsem, David Cunningham, W.W. ten Bokkel Huinink, Cornelis J.A. Punt, C.G. Alexopoulos, L. Dirix, Michel Symann, G.H. Blijham, Philippe Cholet, Georges Fillet, CHRIS VAN GROENINGEN, Jean-Michel Vannetzel, Françis Lévi, G Panagos, Clemens Unger, J. Wils, Claudia Côté, (unknown), Patrice Herait, Harry Bleiberg	1999	98
14	The First World Conference on Clinical Cooperative Research for Lung Cancer, Brussels 4–6 March 1999☆ Lung Cancer ·J.P. Sculier, Vincent Ninane, Anna Efremidis, J.J. Lafitte, P VANHOUTTE, C.G. Alexopoulos, J Thiriaux, Jean Klášterský	1999	0
15	Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party. Journal of Clinical Oncology ·Sculier Jp, Marianne Paesmans, J Thiriaux, J. Lecomte, G. Bureau, V. Giner, Anna Efremidis, J.J. Lafitte, M.C. Berchier, C.G. Alexopoulos, C Zacharias, P. Mommen, Vincent Ninane, Jean Klášterský	1998	24
16	Changes in serum lipids and lipoproteins in cancer patients during chemotherapy Cancer Chemotherapy and Pharmacology ·C.G. Alexopoulos, Stavros Pournaras, Michael Vaslamatzis, Alec Avgerinos, S. Raptis	1992	51
17	Serum lipids and lipoprotein disorders in cancer patients Cancer ·C.G. Alexopoulos, B. Blatsios, Alec Avgerinos	1987	106
18	Primary gastric lymphoma – The experience of a General Hospital British Journal of Cancer ·Theofanis Economopoulos, C.G. Alexopoulos, N. Stathakis, S. Styloyannis, John Dervenoulas, S. Tsousis, S. Raptis	1985	40
19	Cancer of the ovary: a summary of experience with cis-dichlorodiammineplatinum(II) at the Royal Marsden Hospital. PubMed ·E. Wiltshaw, S Subramarian, C.G. Alexopoulos, Barker Gh	1980	60
20	Immunological monitoring during chemotherapy for advanced Hodgkin's disease Cancer ·C.G. Alexopoulos, E. Wiltshaw	1978	11

About C.G. Alexopoulos

C.G. Alexopoulos is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Hematology, having authored 34 papers that have together received 789 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers), Cancer Treatment and Pharmacology (4 papers), Cancer, Lipids, and Metabolism (4 papers), Gastric Cancer Management and Outcomes (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Inflammatory Biomarkers in Disease Prognosis (3 papers). The work is most often cited by research in Oncology (421 citations), Hepatology (118 citations), Cancer Research (131 citations), Pulmonary and Respiratory Medicine (219 citations) and Pathology and Forensic Medicine (106 citations). C.G. Alexopoulos has collaborated with scholars based in Greece, Belgium and United Kingdom. Frequent co-authors include Alec Avgerinos, Michael Vaslamatzis, E. Wiltshaw, S. Raptis, Theofanis Economopoulos, Vincent Ninane, Jean Klášterský, J. Lecomte, Marianne Paesmans and Anna Efremidis. Their work appears in journals such as European Journal of Cancer, British Journal of Cancer, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact